Ultragenyx Pharmaceutical...

44.60
0.31 (0.70%)
At close: Feb 20, 2025, 3:59 PM
44.48
-0.27%
After-hours: Feb 20, 2025, 04:00 PM EST

Ultragenyx Pharmaceutical Inc. Forecast

Stock Price Forecast

The 14 analysts with 12-month price forecasts for RARE stock have an median target of 84.5, with a low estimate of 48 and a high estimate of 140. The median target predicts an increase of 89.46% from the current stock price of 44.60.

Analyst Consensus: Buy
Target Low Average Median High
Price $48 $93.5 $84.5 $140
Change 7.62% 109.64% 89.46% 213.90%

AI Analyst Report

HC Wainwright & Co. maintains a Buy rating on Ultr... Unlock content with Pro Subscription

Updated Feb 18, 2025

Rating Sep 24Oct 24Nov 24Dec 24Jan 25Feb 25
Strong Buy 012001
Buy 324222
Hold 000010
Sell 000000
Strong Sell 000000
Total 3 3 6 2 3 3

Financial Forecast this Year

Revenue This Year
547.60M
from 434.25M
Increased by 26.1%
Revenue Next Year
653.45M
from 547.60M
Increased by 19.3%
EPS This Year
-6.19
from -8.25
Increased by 25.0%
EPS Next Year
-5.18
from -6.19
Increased by 16.3%